Cells have t o double their protein mass in order t o divide. Whether this is achieved through increased synthesis (PS), decreased degradation (PD), or a combination of both is still debated. Likewise open are other basic questions:
CELL PROTEIN MASS
Mitosis is the final event in cell proliferation. In order to divide, cells have (i) to double their mass and (ii) to replicate their genetic material (1). On the ground of experiments wherein rRNA was taken as a parameter for cell mass, evidence has been provided for these two basic processes as being subjected to distinct regulations (I, 2). Intuitively, however, a strict coordination must exist between Prcscnted at thc Sccond International Symposium sponsored by thc Universities of Sassari and Cagliari, Session 11: "Characterization of hletabolic and Biological Pattcrns." Octobcr 12-15. 1983. Alghcro. Italy. This symposium section will be continued in Volumc 12. Numbcr 4. 1984.
them for cells to maintain a constant mass through divisions. Although unbalanced growth is not totally forbidden, it only occurs under particular circumstances and, by necessity, is a self-limiting event (3) (4) (5) .
How and where exactly in the proliferative cycle the above coordination is brought into effect is still matter of debate and speculation, with a full range of opinions strictly conforming to probabilistic as opposed to deterministic models or reflecting various combinations of these extreme points of view (cf. Ref. 6 ). These problems, however, are beyond the scope of the present discussion.
A detailed descriptive analysis of cell mass 282 BACCINO, TESSITORE, AND BONELLI TOXICOLOGIC PATHOLOGY regulation through the cell cycle as well as in nonproliferative states has been provided by the use of multiparametric flow cytometry techniques (7, 8) . Two general points emerge that are relevant to the present discussion: (a) in proliferating populations, constancy of cell mass is maintained through the cycle, within limits of individual variability which are maximal just after cytokinesis and minimal by mid-G1 (equalization point): (b) in several cell types examined, deep quiescence (GO) is characterized by a reduction in cell mass and growth phase transitions in either direction require some time during which cell mass is adjusted to the proper level.
CELL. PROTEIN TURNOVER
Heterogeneity and selectivity are prominent features of cell protein turnover, suggesting that distinct regulations may exist for individual molecular species and/or different subcellular compartments (9,lO) . Apparently superimposed on these heterogeneities, there exists, a general regulation of protein turnover that basically involves the pool of slowturnover proteins (11). With the approximations affecting any generalization, fast turnover with distinctly individual properties is a characteristic of regulatory proteins, whereas structural or nonregulatory proteins are turned over at slow and relatively homogeneous rates.
Cell protein degradation is a general function served by multiple mechanisms with possible redundancies. Information on these mechanisms has greatly improved in the last few years (12), yet many uncertainties and black boxes still exist. Lysosomes play an important role as a final common pathway for a large share of protein degradation. The appreciation of this role largely rests on the discovery and use of selective inhibitors (13-15). The rate-limiting step in the lysosomal pathway is usually thought to be the sequestration of substrates into the lysosome-vacuolar apparatus by autophagy or related processes. Although in these phenomena selectivity is not inconceivable, at present the prevailing view is that lysosomes are mainly involved in the degradation of proteins having slow and relatively homogeneous turnover. Nevertheless, evidence has been recently provided that even fast-turnover proteins are both segregated and degraded in lysosomes (16, 17) .
A large body of evidence indicates that regulation of the intracellular concentration of individual proteins as well as of the total protein mass rests on both synthetic and degradative controls and, in particular, that degradation is liable to very extensive modulations. In the discussion that follows, proteins are only considered from an overall qua& tative point of view and, as far as protein turnover is concerned, reference is only made to the pool of slow-turnover proteins, which by and large includes 95% of the cell protein mass (18) . Although protein turnover is heterogeneous, appropriate experimental conditions can be selected that allow adequate estimates of bulk protein turnover and consistent analyses of overall synthesis, degradation, and accumulation of cell protein.
Individual proteins may, and do, deviate drastically from the general pattern: although these occurrences have to be acknowledged, they do not invalidate the general approach outlined above.
GKOWTH-ASSOCIATED REGULATION OF PROTEIN DEGRADATION
Cell growth-phase transitions require adequate control of protein turnover (synthesis and degradation) in order to balance synthesis and degradation for growth to cease (not considering here cell losses) or, alternatively, to increase the protein mass up to the level needed for cells to divide (irrespective of whether the critical mass has a regulatory or a purely permissive role in the proliferative control). Theoretically, this control could bear on either the anabolic or the catabolic aspect of turnover or on both of them. Available data indicate, indeed, that each of these possibilities can be operative, depending on the cell type as well as, to some extent at least, on the experimental conditions (19).
The concept of growth-associated regulation of cell protein degradation (19) presently rests on a large and sound body of evidence. Data from this as well as other laboratories clearly prove that cells of many different types restrict protein degradation in the growth state, as compared with quiescence, or accelerate it when proliferation ceases.
The key point here is that restricted degradation may contribute even more than enhanced synthesis to protein accumulation in growing cell populations. Reciprocally, protein degradation may have to be enhanced, even markedly, in order to balance synthesis Vol. 12, No. 3,1984 PROTEIN METABOLISM 283 for cells to attain growth arrest. A few examples will illustrate these regulations.
Liver
In liver tissue, protein accumulation in adult liver during compensatory growth after two-thirds hepatectomy is accomplished by increasing protein synthesis and, particularly, by restricting protein degradation (20, 21) . Although no clearcut evidence is available so far, this regulation of protein catabolism has been suggested to mainly reflect suppression of autophagy (22), i.e., reduced functioning of the lysosomal pathway, which is known to be very active in resting liver cells (23, 24) . Moreover, a selective decline of lysosomal proteinase and other hydrolase activities has been demonstrated in the regenerating liver (25) and specifically located in cycling hepatocytes (26) .
Other conditions of liver cell proliferation are likewise associated with reduction of protein breakdown as well as of lysosomal proteinase activities. During developmental growth, protein synthesis is higher while degradation is lower in comparison with rates in adult steady-state tissue (27) , and the lysoso-ma1 proteinase equipment is less represented (25) . A further reduction in proteinase activities is observed in correspondence with a synchronous wave of hepatocytic mitoses elicited in 1-week-old rats by casein-hydrocortisone (25).
3T3 Cells
A variety of cultured cells effect a combined regulation of protein turnover, including both synthesis and degradation, in relation to the growth phase and rate; other cell types apparently adopt a simple regulation of protein synthesis alone. Readers are referred to a recent concise review of the literature (19) .
Balb/c mouse normal 3T3 fibroblasts offer a good example to illustrate the strategy adopted by many growth-controlled populations to shift the protein balance from zero to a positive value, or vice versa, along with growth-phase transitions. Monolayers of 3T3 cells exhibit the characteristic density-dependent regulation of growth. After an exponential phase, with a growth fraction of or close to 1, they reach a stationary phase wherein proliferation ceases, because cells enter a state of deep quiescence (GO), with a growth fraction of or close to o (virtually no cell turnover); growth arrest is due to depletion of serum platelet-derived growth factor and possibly to other factors relating to contact phenomena (e.g., Ref. 28) . The protein balance can be expressed in the form of an equation, which relates the fractional rates of protein accumulation (or growth: k"), synthesis (k,), and degradation (kc{), all expressed as percentage/hr. Based on data of Lockwood et al. (29, 30) , the equation has the following values for exponential (log; t(J = 14 hr) and stationary (sta) cells, respectively:
Clearly, enhancement in degradation does contribute nearly as much as reduction in synthesis in zeroing the protein balance. Of interest, very similar figures have been recently reported (31) for bone marrow-derived monocytes shifted from quiescence to growth under the influence of CSF-I.
How the growth-associated regulation of protein degradation operates in 3T3 cells has been elucidated in a collaborative work between Lockwood and our group (30) . In confluent, quiescent cells protein degradation is largely suppressed by inhibitors of the lyso-soma1 pathway such as leupeptin and chloroquine, down to the ?%/hr rate measurable in growing cells. By contrast, these inhibitors are virtually ineffective on growing cells. Thus, quiescent 3T3 cells elevate protein degradation by activating the lysosomal pathway. Qualitatively similar results have already been reported (32) .
Further available informations concerning the organization and proteolytic equipment of the lysosomal apparatus 3T3 cells are probably relevant. These cells operate a densitydependent regulation of lysosomal enzymes such as the aspartic proteinase cathepsin D (29, 30, 33) and the cysteine proteinases cathepsins B, L, and H (G. Bonelli and coworkers, unpublished), which increase severalfold in activity with time in culture. Moreover, immunofluorescent staining with anti-cathepsin D antibodies reveals that 3T3 cells have a richly developed lysosomal apparatus, consisting of a great number of tiny granules, particularly crowded in the perinuclear area (30) . It seems possible that both the modulation of cathepsin activities and the abundance of lysosomal structures are instrumen-284 BACCINO, TESSITORE, AND BONELLI TOXICOLOGIC PATHOLOGY tal in the conspicuous growth-associated regulation of protein degradation featured by these cells.
PROTEIN DEGRADATION I N NEOPLASTIC CELLS
Growth corresponds to a positive balance between protein synthesis and degradation, and growth control requires the ability of cells to balance synthesis and degradation. A selective growth advantage for transformed or tumoral over normal cells might arise from a defective regulation of protein degradation in the former ones (19, 33, 34) . A variety of transformed or tumoral cells do indeed exhibit lower proteolytic rates than their normal counterparts, as already reported in a concise review'(19). However, measurements and actual rates of protein degradation are affected by many variables, including growth phase or rate, as discussed above. Therefore, only carefully designed experiments can provide adequate information. Two models recently investigated have offered the opportunity for a detailed analysis, which is illustrated below.
Transformed 3T3 Cells SV-40 virus-transformed 3T3 cells (SV-3T3) lack any density-dependent regulation of growth. Due to an extremely reduced requirement for serum factors, unlike normal 3T3 cells, they grow exponentially u p to high densities, after which growth rapidly declines and cultures die due to spoilage of medium. Therefore, only low-and high-density cultures can be compared, the latter being taken before the occurrence of extensive cell losses. Based on data by Lockwood et al. (30, 35) , the protein balance equation has these figures: k,, = k,k d Low density 6.5 = 7.5 -1 High density 2 = 3 -1 Therefore, while maximally growing SV-3T3 cells ( I d = 11 hr) strictly resemble exponential 3T3 cells, at very crowded densities they markedly reduce protein synthesis, yet fail to elevate degradation; thence protein accumulation cannot be zeroed until suicidal cell death. Furthermore, protein degradation at both low and high densities is virtually unaffected by lysosomal inhibitors such as leupeptin and chloroquine. The activity levels of cathepsins D, B, L, and H (33) (G. Bonelli and coworkers, unpublished) are lower than in sparse 3T3 cells and do not show any density-dependent regulation. By immunofluorescence microscopy with anti-cathepsin D antibodies, the lysosomal granules are markedly reduced in number and increased in size, in comparison with 3T3 cells, which might be indicative of substantial differences in the functioning of the lysosomal apparatus in these transformed versus normal cells (30) .
Yoshida Ascites Hepatoma AH-130
This highly-deviated ascites hepatoma provides a suitable model to study growth-related protein turnover states (36) , since after transplantation it grows exponentially, but in about a week (depending on the inoculum size) it reaches a quasi-stationary state. Cessation of growth, however, does not reflect real growth control. Due to the limited supply of oxygen and nutrients, cells do not enter GO, but rather stop in a state, from which they promptly resume progression into cycle as soon as the environment becomes adequate (37) . Measurements of protein turnover over the exponential and stationary phases of growth gives the following figures for the protein balance equation: k,, = k,k d log tumor sta tumor 2.5 = 3.1 -0.6 0.1 = 1.5 -1.4
Thence, protein degradative rates are quite low when cells grow exponentially (fd = 25 hr), but they are definitely elevated in growth-arrested cells. Net protein accumulation ceases owing to convergent alterations in both synthesis and degradation rates.
The proteolytic mechanism involved in the above regulation can be analyzed on cells incubated in vitro to measure the release of acid-soluble radioactivity, 24 hr after protein labeling in vivo. The use of a variety of inhibitors shows that virtually all of the elevation of protein catabolism in stationary versus proliferating cells results from activation of the lysosomal pathway, while lysosomal inhibitors are virtually ineffective on growing cells.
Like transformed 3T3 cells (see "Transformed 3T3 cells"), however, these AH-130 cells lack any growth-associated regulation of lysosomal proteinase activities. Of interest, levels of these and other hydrolase activities are much lower in AH-130 cells than in adult liver tissue, in most cases approximately by an order of magnitude (if expressed per mg Vol. 12, No. 3,1984 PROTEIN METABOLISM 285 of protein). By contrast, protein-degradative rates in growth-arrested tumor cells are quite close to those in adult liver tissue (231, when measured under comparable conditions.
CONTROL OF PROTEIN DEGRADATION IN NORMAL VERSUS NEOPLASTIC GROWTH
In a11 of the model systems considered above, which include both tissues and cultured cells, normal and neoplastic populations, cessation of growth always implies a convergent regulation of protein anabolism and catabolism, i.e., decreased synthesis and enhanced degradation of proteins of the general, slow-turnover pool. Cells such as SV-3T3, unable to achieve a stationary phase of growth, also fail to elevate protein degradation, even when protein synthesis (and growth) is declining at very crowded densities. This is not to say, however, that the occurrence of a growth-associated regulation of protein degradation must be regarded as mandatory for growth to be controlled (cf. "Growth-associated Regulation of Protein Degradation") 119).
As far as presently understood, the growthassociated regulation of protein degradation is largely, if not completely, operated by modulating the functioning of the lysosomal pathway. This is indeed a rather usual device adopted by cells to adjust protein turnover to their variables needs (13, 19) .
The elevation of protein degradation in growth-arrested cells is virtually all suppressible by agents that interfere with the lysosomal mode of protein degradation at any of the steps thus far discriminated. Such a conclusion is particularly compelling for cells such as 3T3 and AH-130 hcpatoma, wherein protein degradation is virtually not affected by lysosomal inhibitors when they are in the growth state. By contrast, that mode (or modes) of degradation which is not suppressible with lysosomal inhibitors apparently is not involved at all in this growth-associated regulation; in this sense, it looks like a nondispensable function of cell metabolism.
Acceleration of protein degradation through the lysosomal pathway does not require, per se, a corresponding increase in the lysosomal proteolytic equipment of cells, as clearly shown by data on AH-130 tumor. Although comparatively poor in lysosomal cathepsin activities, on growth arrest these cells can markedly accelerate the lysosomal proteolysis without any increase in cathepsin levels. This data corroborates the concept that usually protein sequestration into lysosomes is the main rate-limiting step for this pathway. Of interest, the sequestration of microinjected inert molecules into lysosomes, taken as a measure of autophagic activity, was found enhanced in quiescent versus proliferating fibroblasts in culture (38) .
Among the cell systems examined above, liver and normal 3T3 cells do regulate lysosomal proteinase activity levels versus the growth phase or cell density, whereas AH-130 tumor and transformed 3T3 cells do not. Thence, the occurrence of this regulation cannot be merely associated with the ability of cells to arrest growth per se. Rather, this function can be possibly conceptualized as a modulation (differentiation?) only shared by cells capable of entering GO, i.e., an active metabolic state of deep quiescence, and thus is defective in neoplastic cells.
The precise nature of the relationship between changes in protein catabolic rates and cathepsin activity levels remains to be assessed. There are reasons to suspect, however, that the lysosomal machinery may be operating at saturation in stationary AH-130 tumor cells, possibly because of the limited availability of proteinases. If correct, this hypothesis could offer a clue to account for the fact that, although these tumor cells can elevate protein degradative rates to attain a nongrowth state, this regulation is inadequate to prevent excessive tumor growth as well as cachexia and death of the host animals.
How precisely the above regulation of protein degradation is coupled to recruitment or progression into cell cycle and which are the signals for it we do not know as yet. Several growth factors have indeed been shown to determine some reduction of proteolytic rates in a variety of cultured normal or neoplastic cells (39) , yet the relevance of this effect to the growth state was not assessed.
Conceivably, a defective regulation of protein degradation could offer a selective advantage to neoplastic versus normal cells. This advantage could be both effective in terms of metabolic competition with host cells (as discussed above for AH-130 tumor] and instrumental in the relaxation of growth control.
At a cellular level, growth in population size may reflect not only the cell birth rate (as determined by growth fraction and cell cycle time), but also the cell loss. Much in the same way, one has to acknowledge that, 286 BACCINO, TESSITORE, in terms of protein accumulation, growth is a function of the production of new molecules as well as of the molecular loss (turnover and secretion). Whether enhancement of molecular loss may be a practical way to encourage reluctant cells, such as the tumoral ones, to cease growth still remains an elusive albeit conceivable possibility.
